Overall Survival for Non-Small Cell Lung Cancer Patients Receiving Surgery Plus Chemoradiation Increased Compared to those Receiving Chemoradiation Alone
CHICAGO, IL (June 2, 2010) – Research from Fox Chase Cancer Center shows that patient’s with stage IIIA NSCLC who receive surgery, lobectomy in particular, have increased overall survival compared to those who received chemoradiation alone––those receiving lobectomy plus chemoradation had survival rates that were higher than previously reported as well.